Sort
16,300 grants matching “fatty liver disease”
Bmal1, a master regulator of Macrophage cholesterol metabolism
$533,829Xiaoyue Pan · New York University D/B/A Nyu Long Island School Of Medicine · R01 · FY2025 · HL
New Targets of Thyroid Hormone Action
$533,374Anthony N Hollenberg · Beth Israel Deaconess Medical Center · R01 · FY2013 · DK
Novel effectors of insulin action in the liver
$533,354Fajun James Yang · Albert Einstein College Of Medicine · R01 · FY2021 · DK
Novel effectors of insulin action in the liver
$533,354Fajun James Yang · Albert Einstein College Of Medicine · R01 · FY2022 · DK
Novel effectors of insulin action in the liver
$533,354Fajun James Yang · Albert Einstein College Of Medicine · R01 · FY2020 · DK
Novel effectors of insulin action in the liver
$533,354Fajun James Yang · Albert Einstein College Of Medicine · R01 · FY2023 · DK
Metabolic Crosstalk During Hepatic Insulin Resistance
$533,189Morris F. White · Boston Children'S Hospital · R01 · FY2019 · DK
Host-Microbiota-Diet Interactions in Metabolic Syndrome and IBD
$533,139Andrew T Gewirtz · Georgia State University · R01 · FY2020 · DK
Role of Sensory Innervation in High Fat Diet-Induced Hepatotoxicity
$533,046Gianfranco D. Alpini · Indiana University Indianapolis · R01 · FY2023 · DK
Epigenetic markers of severity in nonalcoholic fatty liver disease
$532,877Johanna K Distefano · National Jewish Health · R01 · FY2017 · DK
Regulation of Sex Differences in Liver Metabolism
$532,861David J Waxman · Boston University (Charles River Campus) · R01 · FY2016 · DK
Environmental Obesogens and Weight Change in the POUNDS LOST Trial
$532,753Qi Sun · Harvard School Of Public Health · R01 · FY2016 · ES
The UPR and CaMKIIg in Atherosclerosis and Insulin Resistance
$532,486Ira A Tabas · Columbia University Health Sciences · P01 · FY2014 · HL
Applied Research Component: Cryopreservation
$532,439Steven Loyal Britton · University Of Michigan At Ann Arbor · P40 · FY2015 · OD
Resource for Rat Genetic Models of Aerobic Capacity
$532,439Steven Loyal Britton · University Of Michigan At Ann Arbor · P40 · FY2015 · OD
Fibroblast growth factor 1 prevents hyperlipidemia and atherosclerosis
$532,418Yi Tan · University Of Louisville · R01 · FY2025 · HL
Therapeutic Potential of FGF21 for Alzheimer's Disease
$532,372Matthew Joseph Potthoff · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2025 · AG
Integrative Physiology of Thyroid Hormone Receptors and Nuclear Receptor Corepressors
$532,334Mitchell A. Lazar · University Of Pennsylvania · R01 · FY2018 · DK
Integrative Physiology of Thyroid Hormone Receptors and Nuclear Receptor Corepressors
$532,334Mitchell A. Lazar · University Of Pennsylvania · R01 · FY2019 · DK
Integrative Physiology of Thyroid Hormone Receptors and Nuclear Receptor Corepressors
$532,334Mitchell A. Lazar · University Of Pennsylvania · R01 · FY2022 · DK
Cellular and Biochemical Pathways of Adipose Metabolism and Thermogenesis
$532,254Bruce M Spiegelman · Dana-Farber Cancer Inst · R01 · FY2021 · DK
Cellular and Biochemical Pathways of Adipose Metabolism and Thermogenesis
$532,254Bruce M Spiegelman · Dana-Farber Cancer Inst · R01 · FY2020 · DK
Cellular and Biochemical Pathways of Adipose Metabolism and Thermogenesis
$532,254Bruce M Spiegelman · Dana-Farber Cancer Inst · R01 · FY2022 · DK
Cellular and Biochemical Pathways of Adipose Metabolism and Thermogenesis
$532,254Bruce M Spiegelman · Dana-Farber Cancer Inst · R01 · FY2023 · DK
Development of Controlled Release Mitochondrial Protonophore (CRMP) as a Novel Treatment for Type-2 Diabetes and Non-Alcoholic Steatohepatitis in Dysmetabolic Non-Human Primates
$532,148Gerald I Shulman · Yale University · R01 · FY2023 · DK